.Attributes Medication, Released online: 09 October 2024 doi:10.1038/ s41591-024-03316-9Delandistrogene moxeparvovec acquired FDA confirmation after a bad trial, which highlights the various intricacies and also difficulties of drug advancement in this particular setup.